Pharma ESG efforts overwhelmingly skew social, while environment and governance come up short: studynews2021-08-18T23:32:28+00:00August 18th, 2021|Fierce Pharma|
Lilly, Boehringer Ingelheim’s Jardiance scores heart failure FDA nod, and an even bigger win could come later this yearnews2021-08-18T20:21:06+00:00August 18th, 2021|Fierce Pharma|
White House rolls out COVID-19 booster plan, but the FDA and CDC have yet to have their saynews2021-08-18T19:48:38+00:00August 18th, 2021|Fierce Pharma|
‘Our worst nightmare realized:’ Investors, WHO slam J&J for exporting COVID shots produced in Africanews2021-08-18T19:18:14+00:00August 18th, 2021|Fierce Pharma|
CSL’s Seqirus delivers record number of flu vaccines despite pandemic, and now it’s eyeing next-gen mRNA shotsnews2021-08-18T15:38:24+00:00August 18th, 2021|Fierce Pharma|
Galderma tackles ‘maskne,’ one of many skin concerns exploding during pandemicnews2021-08-18T15:29:54+00:00August 18th, 2021|Fierce Pharma|
Regeneron, GlaxoSmithKline COVID-19 antibodies in high demand as Delta drives a pandemic surgenews2021-08-18T15:26:04+00:00August 18th, 2021|Fierce Pharma|
GSK’s Jemperli follows Merck’s Keytruda with FDA nod to target certain tumors regardless of locationnews2021-08-18T13:37:31+00:00August 18th, 2021|Fierce Pharma|
Inching closer to buyout, Philip Morris grabs stake in respiratory specialist Vectura as health groups push backnews2021-08-18T13:28:28+00:00August 18th, 2021|Fierce Pharma|
Conde Nast Health continues to court pharma advertisers with new media content including Twitter hookupnews2021-08-18T10:44:54+00:00August 18th, 2021|Fierce Pharma|
